Table 3 Effects of curcumin and/or coenzyme Q10 supplementation on metabolic syndrome components ^a

 Week 0

224.7 ± 66.9

244.6 ± 95.2

236.8 ± 64.1

231.7 ± 80.7

 Week 12

166.7 ± 72.8

234.8 ± 39.4

220.8 ± 73.7

237.8 ± 88.6

 Mean difference

−58.0 ± 49.1

−9.8 ± 30.4

−16.0 ± 48.4

6.1 ± 59.5

 P_{within groups}

<  0.001

0.08

0.01

0.51

 Week 0

32.0 ± 5.6

32.9 ± 4.7

31.2 ± 7.5

33.3 ± 8.5

 Week 12

42.0 ± 5.9

33.9 ± 4.6

33.0 ± 7.6

34.2 ± 8.6

 Mean difference

10.0 ± 5.3

1.0 ± 4.5

1.8 ± 4.6

0.9 ± 6.9

 P_{within groups}

<  0.001

0.43

0.25

0.40

 Week 0

130.2 ± 7.5

127.2 ± 10.8

126.2 ± 10.4

135.1 ± 14.2

 Week 12

130.8 ± 8.4

126.2 ± 9.9

125.2 ± 9.7

134.9 ± 15.2

 Mean difference

0.6 ± 8.1

−1.0 ± 9.7

−1.0 ± 9.3

−0.2 ± 12.8

 P_{within groups}

0.74

0.42

0.40

0.64

 Week 0

91.0 ± 8.4

92.0 ± 7.9

93.1 ± 6.7

92.6 ± 6.5

 Week 12

91.5 ± 6.6

91.1 ± 8.5

92.1 ± 4.3

91.8 ± 9.9

 Mean difference

0.5 ± 7.5

− 0.9 ± 8.3

−1.0 ± 5.5

− 0.8 ± 7.9

 P_{within groups}

0.31

0.51

0.45

0.56

 Week 0

101.0 ± 8.4

102.1 ± 6.5

102.7 ± 6.6

101.8 ± 7.7

 Week 12

100.2 ± 8.5

101.5 ± 7.3

102.1 ± 8.6

101.4 ± 7.4

 Mean difference

−0.8 ± 4.0

− 0.6 ± 3.6

−0.6 ± 4.0

−0.4 ± 3.9

 P_{within groups}

0.08

0.11

0.10

0.20

 Week 0

130.1 ± 9.7

128.2 ± 14.3

121.2 ± 9.8

130.1 ± 14.7

 Week 12

126.2 ± 8.5

126.2 ± 15.4

118.9 ± 8.2

126.3 ± 13.8

 Mean difference

−3.9 ± 7.3

−2.0 ± 9.3

−3.3 ± 7.3

−3.8 ± 9.7

 P_{within groups}

0.40

0.67

0.45

0.40